 | RDC | 表記: | RADICICOL | 組成式: | C18 H17 Cl O6 | SMILES: | O=C2C=CC=CC3OC3CC(OC(=O)c1c(O)cc(O)c(Cl)c1C2)C | InChi: | InChI=1S/C18H17ClO6/c1-9-6-15-14(25-15)5-3-2-4-10(20)7-11-16(18(23)24-9)12(21)8-13(22)17(11)19/h2-5,8-9,14-15,21-22H,6-7H2,1H3/b4-2+,5-3-/t9-,14-,15-/m1/s1 | 別名: | MONORDEN | 定義日: | 1999-07-08 | 最終更新日: | 2020-06-17 | 識別子(ID): | (1aR,2Z,4E,14R,15aR)-8-chloro-9,11-dihydroxy-14-methyl-1a,14,15,15a-tetrahydro-6H-oxireno[e][2]benzoxacyclotetradecine-6,12(7H)-dione |
|
 | RDG | 表記: | 2'-deoxy-N-(furan-2-ylmethyl)guanosine 5'-(dihydrogen phosphate) | 組成式: | C15 H18 N5 O8 P | SMILES: | O=P(O)(O)OCC4OC(n3cnc2c3N=C(NCc1occc1)NC2=O)CC4O | InChi: | InChI=1S/C15H18N5O8P/c21-9-4-11(28-10(9)6-27-29(23,24)25)20-7-17-12-13(20)18-15(19-14(12)22)16-5-8-2-1-3-26-8/h1-3,7,9-11,21H,4-6H2,(H2,23,24,25)(H2,16,18,19,22)/t9-,10+,11+/m0/s1 | 別名: | N2-furfuryl-deoxyguanosine-5'-monophosphate | 定義日: | 2013-04-22 | 最終更新日: | 2020-06-17 | 公開日: | 2015-05-06 | 識別子(ID): | 2'-deoxy-N-(furan-2-ylmethyl)guanosine 5'-(dihydrogen phosphate) |
|
 | 85F | 表記: | (2R)-2-azanyl-3-[(2R)-2-azanyl-3-oxidanyl-3-oxidanylidene-propyl]sulfanyl-propanoic acid | 組成式: | C6 H12 N2 O4 S | SMILES: | N[CH](CSC[CH](N)C(O)=O)C(O)=O | InChi: | InChI=1S/C6H12N2O4S/c7-3(5(9)10)1-13-2-4(8)6(11)12/h3-4H,1-2,7-8H2,(H,9,10)(H,11,12)/t3-,4-/m0/s1 | 別名: | L-Lanthionine | 定義日: | 2017-04-20 | 最終更新日: | 2020-06-17 | 公開日: | 2018-04-11 | 識別子(ID): | (2~{R})-2-azanyl-3-[(2~{R})-2-azanyl-3-oxidanyl-3-oxidanylidene-propyl]sulfanyl-propanoic acid |
|
 | RE2 | 表記: | 5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol | 組成式: | C14 H14 O3 | SMILES: | Oc1cc(cc(O)c1)CCc2ccc(O)cc2 | InChi: | InChI=1S/C14H14O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h3-9,15-17H,1-2H2 | 別名: | Dihydroresveratrol | 定義日: | 2009-01-19 | 最終更新日: | 2020-06-17 | 識別子(ID): | 5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol |
|
 | RE8 | 表記: | 4-[(E)-(2-hydroxynaphthalen-1-yl)diazenyl]naphthalene-1-sulfonic acid | 組成式: | C20 H14 N2 O4 S | SMILES: | O=S(=O)(O)c4ccc(/N=N/c2c1ccccc1ccc2O)c3ccccc34 | InChi: | InChI=1S/C20H14N2O4S/c23-18-11-9-13-5-1-2-6-14(13)20(18)22-21-17-10-12-19(27(24,25)26)16-8-4-3-7-15(16)17/h1-12,23H,(H,24,25,26)/b22-21+ | 別名: | Acid red 88 | 定義日: | 2013-03-13 | 最終更新日: | 2020-06-17 | 公開日: | 2014-02-12 | 識別子(ID): | 4-[(E)-(2-hydroxynaphthalen-1-yl)diazenyl]naphthalene-1-sulfonic acid |
|
 | 869 | 表記: | (1-TERT-BUTYL-5-HYDROXY-1H-PYRAZOL-4-YL)[6-(METHYLSULFONYL)-4'-METHOXY-2-METHYL-1,1'-BIPHENYL-3-YL]METHANONE | 組成式: | C23 H26 N2 O5 S | SMILES: | O=C(c1c(O)n(nc1)C(C)(C)C)c3ccc(c(c2ccc(OC)cc2)c3C)S(=O)(=O)C | InChi: | InChI=1S/C23H26N2O5S/c1-14-17(21(26)18-13-24-25(22(18)27)23(2,3)4)11-12-19(31(6,28)29)20(14)15-7-9-16(30-5)10-8-15/h7-13,27H,1-6H3 | 別名: | (1-TERT-BUTYL-5-HYDROXY-1H-PYRAZOL-4-YL)-(6-METHANESULFONYL-4'-METHOXY-2-METHYL-BIPHENYL-3-YL)-METHANONE | 定義日: | 2004-03-29 | 最終更新日: | 2020-06-17 | 識別子(ID): | (1-tert-butyl-5-hydroxy-1H-pyrazol-4-yl)[4'-methoxy-2-methyl-6-(methylsulfonyl)biphenyl-3-yl]methanone |
|
 | 86B | 表記: | 4-{(2S)-2-hydroxy-3-[(propan-2-yl)amino]propoxy}benzene-1-sulfonamide | 組成式: | C12 H20 N2 O4 S | SMILES: | c1(S(=O)(=O)N)ccc(cc1)OCC(CNC(C)C)O | InChi: | InChI=1S/C12H20N2O4S/c1-9(2)14-7-10(15)8-18-11-3-5-12(6-4-11)19(13,16)17/h3-6,9-10,14-15H,7-8H2,1-2H3,(H2,13,16,17)/t10-/m0/s1 | 別名: | aryloxy-2-hydroxypropylammine sulfonamide | 定義日: | 2017-08-02 | 最終更新日: | 2020-06-17 | 公開日: | 2018-08-01 | 識別子(ID): | 4-{(2S)-2-hydroxy-3-[(propan-2-yl)amino]propoxy}benzene-1-sulfonamide |
|
 | REF | 表記: | 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione | 組成式: | C14 H6 O8 | SMILES: | O=C1Oc3c2c4c1cc(O)c(O)c4OC(=O)c2cc(O)c3O | InChi: | InChI=1S/C14H6O8/c15-5-1-3-7-8-4(14(20)22-11(7)9(5)17)2-6(16)10(18)12(8)21-13(3)19/h1-2,15-18H | 別名: | Ellagic acid, 4,4',5,5',6,6'-Hexahydroxydiphenic acid 2,6,2',6'-dilactone | 定義日: | 2008-03-12 | 最終更新日: | 2020-06-17 | 識別子(ID): | 2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione |
|
 | REN | 表記: | (S)-reticuline | 組成式: | C19 H23 N O4 | SMILES: | O(c1ccc(cc1O)CC3c2c(cc(OC)c(O)c2)CCN3C)C | InChi: | InChI=1S/C19H23NO4/c1-20-7-6-13-10-19(24-3)17(22)11-14(13)15(20)8-12-4-5-18(23-2)16(21)9-12/h4-5,9-11,15,21-22H,6-8H2,1-3H3/t15-/m0/s1 | 別名: | (1S)-1-(3-hydroxy-4-methoxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol | 定義日: | 2008-06-04 | 最終更新日: | 2020-06-17 | 識別子(ID): | (1S)-1-(3-hydroxy-4-methoxybenzyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol |
|
 | REW | 表記: | (2S,3S)-1-(4-METHOXYPHENYL)-3-(3-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)BENZYL)-4-OXOAZETIDINE-2-CARBOXYLIC ACID | 組成式: | C30 H28 N2 O6 | SMILES: | O=C(O)C2N(c1ccc(OC)cc1)C(=O)C2Cc5cc(OCCc3nc(oc3C)c4ccccc4)ccc5 | InChi: | InChI=1S/C30H28N2O6/c1-19-26(31-28(38-19)21-8-4-3-5-9-21)15-16-37-24-10-6-7-20(17-24)18-25-27(30(34)35)32(29(25)33)22-11-13-23(36-2)14-12-22/h3-14,17,25,27H,15-16,18H2,1-2H3,(H,34,35)/t25-,27-/m0/s1 | 別名: | 4-[2-(3-{[(2S,3S)-2-carboxy-1-(4-methoxyphenyl)-4-oxoazetidin-3-yl]methyl}phenoxy)ethyl]-5-methyl-2-phenyl-1,3-oxazol-3
-ium | 定義日: | 2007-10-30 | 最終更新日: | 2020-06-17 | 識別子(ID): | (2S,3S)-1-(4-methoxyphenyl)-3-{3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]benzyl}-4-oxoazetidine-2-carboxylic acid |
|
 | 876 | 表記: | N-ACETYL-N-[1-(1,1'-BIPHENYL-4-YLMETHYL)-2-OXOAZEPAN-3-YL]-3,4-DIPHOSPHONOPHENYLALANINAMIDE | 組成式: | C30 H35 N3 O9 P2 | SMILES: | O=P(O)(O)c1ccc(cc1P(=O)(O)O)CC(NC(=O)C)C(=O)NC4C(=O)N(Cc3ccc(c2ccccc2)cc3)CCCC4 | InChi: | InChI=1S/C30H35N3O9P2/c1-20(34)31-26(17-22-12-15-27(43(37,38)39)28(18-22)44(40,41)42)29(35)32-25-9-5-6-16-33(30(25)36)19-21-10-13-24(14-11-21)23-7-3-2-4-8-23/h2-4,7-8,10-15,18,25-26H,5-6,9,16-17,19H2,1H3,(H,31,34)(H,32,35)(H2,37,38,39)(H2,40,41,42)/t25-,26-/m0/s1 | 別名: | RU83876 | 定義日: | 2003-06-20 | 最終更新日: | 2020-06-17 | 識別子(ID): | Nalpha-acetyl-N-[(3S)-1-(biphenyl-4-ylmethyl)-2-oxoazepan-3-yl]-3,4-diphosphono-L-phenylalaninamide |
|
 | 878 | 表記: | 5-IODO-2-(OXALYL-AMINO)-BENZOIC ACID | 組成式: | C9 H6 I N O5 | SMILES: | Ic1cc(c(NC(=O)C(=O)O)cc1)C(=O)O | InChi: | InChI=1S/C9H6INO5/c10-4-1-2-6(5(3-4)8(13)14)11-7(12)9(15)16/h1-3H,(H,11,12)(H,13,14)(H,15,16) | 別名: | NOVO NORDISK A/S COMPOUND | 定義日: | 2000-02-02 | 最終更新日: | 2020-06-17 | 識別子(ID): | 2-[(carboxycarbonyl)amino]-5-iodobenzoic acid |
|
 | RFC | 表記: | (R)-IBUPROFENOYL-COENZYME A | 組成式: | C34 H53 N7 O17 P3 S | SMILES: | O=C(SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC3OC([n+]2cnc1c2ncnc1N)C(O)C3OP(=O)(O)O)C(c4ccc(cc4)CC(C)C)C | InChi: | InChI=1S/C34H52N7O17P3S/c1-19(2)14-21-6-8-22(9-7-21)20(3)33(46)62-13-12-36-24(42)10-11-37-31(45)28(44)34(4,5)16-55-61(52,53)58-60(50,51)54-15-23-27(57-59(47,48)49)26(43)32(56-23)41-18-40-25-29(35)38-17-39-30(25)41/h6-9,17-20,23,26-28,32,43-44H,10-16H2,1-5H3,(H8,35,36,37,38,39,42,45,47,48,49,50,51,52,53)/p+1/t20-,23-,26-,27-,28+,32-/m1/s1 | 別名: | [5-(6-AMINOPURIN-9-YL)-2-[[[[3-[2-(2-(R)-2-[4-(2-METHYLPROPYL)PHENYL] PROPANOYL)-SULFANYLETHYLCARBAMOYL
ETHYLCARBAMOYL]-3-HYDROXY-2,2-DIMETHYL-PROPOXY]-HYDROXY-PHOSPHORYL]OXY-HYDROXY-PHOSPHORYL]OXYMETHYL]-4-HYDROXY-OXOLAN-3-
YL]OXYPHOSPHONIC ACID | 定義日: | 2006-03-23 | 最終更新日: | 2020-06-17 | 識別子(ID): | 6-amino-9-[(2R,3R,4S,5R)-3-hydroxy-4-(phosphonooxy)-5-{(3S,5R,9R,20R)-3,5,9-trihydroxy-8,8-dimethyl-20-[4-(2-methylpropyl)phenyl]-3,5-dioxido-10,14,19-trioxo-2,4,6-trioxa-18-thia-11,15-diaza-3,5-diphosphahenicos-1-yl}tetrahydrofuran-2-yl]-7H-purin-9-ium (non-preferred name) |
|
 | RFS | 表記: | Br-paroxetine | 組成式: | C19 H20 Br N O3 | SMILES: | c4(ccc(C1CCNCC1COc2cc3c(cc2)OCO3)cc4)Br | InChi: | InChI=1S/C19H20BrNO3/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18/h1-6,9,14,17,21H,7-8,10-12H2/t14-,17-/m0/s1 | 別名: | (3S,4R)-3-{[(2H-1,3-benzodioxol-5-yl)oxy]methyl}-4-(4-bromophenyl)piperidine | 定義日: | 2020-02-11 | 最終更新日: | 2020-06-17 | 公開日: | 2020-03-11 | 識別子(ID): | (3S,4R)-3-{[(2H-1,3-benzodioxol-5-yl)oxy]methyl}-4-(4-bromophenyl)piperidine |
|
 | 87X | 表記: | 5-cyclohexylpentanoic acid | 組成式: | C11 H20 O2 | SMILES: | OC(=O)CCCCC1CCCCC1 | InChi: | InChI=1S/C11H20O2/c12-11(13)9-5-4-8-10-6-2-1-3-7-10/h10H,1-9H2,(H,12,13) | 別名: | Cyclohexane-valeric acid | 定義日: | 2017-05-16 | 最終更新日: | 2020-06-17 | 公開日: | 2017-12-06 | 識別子(ID): | 5-cyclohexylpentanoic acid |
|
 | RG1 | 表記: | Rhodopin b-D-glucoside | 組成式: | C46 H66 O6 | SMILES: | C1(OC(C(C(C1O)O)O)CO)OC(C)(C)CCCC(C)=[C@H][C@H]=[C@H]C(C)=[C@H][C@H]=[C@H]C(C)=[C@H][C@H]=[C@H][C@H]=C(C)[C@H]=[C@H][C@H]=C(C)[C@H]=[C@H][C@H]=C(C)[C@H]=[C@H][C@H]=C(C)C | InChi: | InChI=1S/C46H66O6/c1-34(2)19-13-22-37(5)25-16-28-38(6)26-14-23-35(3)20-11-12-21-36(4)24-15-27-39(7)29-17-30-40(8)31-18-32-46(9,10)52-45-44(50)43(49)42(48)41(33-47)51-45/h11-17,19-30,41-45,47-50H,18,31-33H2,1-10H3/b12-11+,22-13+,23-14+,24-15+,28-16+,29-17+,35-20+,36-21+,37-25+,38-26+,39-27+,40-30+/t41-,42-,43+,44-,45+/m1/s1 | 別名: | (3E)-3,4-didehydro-1',2'-dihydro-psi,psi-caroten-1'-yl beta-D-glucopyranoside | 定義日: | 1999-07-08 | 最終更新日: | 2020-06-17 | 識別子(ID): | (3E)-3,4-didehydro-1',2'-dihydro-psi,psi-caroten-1'-yl beta-D-glucopyranoside |
|
 | RGA | 表記: | REIDISPONGIOLIDE A | 組成式: | C54 H87 N O13 | SMILES: | O=CN(C=CCC(OC)C(C(=O)CCC(C)C(OC)C(C)C1OC(=O)C=CC=C(C)CC(OC)CC2=CC(=O)OC(C(C(OC)CC(OC)C=CC(C)C(OC)CC(OC)C=CC1C)C)C2)C)C | InChi: | InChI=1S/C54H87NO13/c1-35-18-16-20-51(58)68-54(41(7)53(66-15)37(3)23-26-46(57)39(5)47(63-12)19-17-27-55(8)34-56)38(4)22-25-43(60-9)32-48(64-13)36(2)21-24-44(61-10)33-49(65-14)40(6)50-30-42(31-52(59)67-50)29-45(28-35)62-11/h16-18,20-22,24-25,27,31,34,36-41,43-45,47-50,53-54H,19,23,26,28-30,32-33H2,1-15H3/b20-16+,24-21+,25-22+,27-17+,35-18+/t36-,37-,38-,39-,40+,41-,43-,44+,45+,47+,48-,49-,50+,53-,54-/m0/s1 | 別名: | N-((E)-4,10-DIMETHOXY-5,9-DIMETHYL-6-OXO-11-((5Z,7Z,13Z,19Z)-3,15,17,21,23-PENTAMETHOXY-5,12,18,24-TETRAMETHYL-9,27-DIO
XO-10,26-DIOXABICYCLO[23.3.1]NONACOSA-1(28),5,7,13,19-PENTAEN-11-YL)DODEC-1-ENYL)-N-METHYLFORMAMIDE | 定義日: | 2005-08-30 | 最終更新日: | 2020-06-17 | 識別子(ID): | N-{(1E,4R,5R,9S,10S,11S)-4,10-dimethoxy-5,9-dimethyl-6-oxo-11-[(3R,5E,7E,11S,12S,13E,15R,17S,18S,19E,21S,23S,24R,25R)-3,15,17,21,23-pentamethoxy-5,12,18,24-tetramethyl-9,27-dioxo-10,26-dioxabicyclo[23.3.1]nonacosa-1(28),5,7,13,19-pentaen-11-yl]dodec-1-en-1-yl}-N-methylformamide |
|
 | RGC | 表記: | REIDISPONGIOLIDE C | 組成式: | C52 H84 O14 | SMILES: | O=C(O)CCC(OC)C(C(=O)CCC(C)C(OC)C(C)C1OC(=O)C=CC=C(C)CC(OC)CC2=CC(=O)OC(C(C(OC)CC(OC)C=CC(C)C(OC)CC(OC)C=CC1C)C)C2)C | InChi: | InChI=1S/C52H84O14/c1-32-16-15-17-49(56)66-52(38(7)51(64-14)34(3)20-23-43(53)36(5)44(61-11)24-25-48(54)55)35(4)19-22-40(58-8)30-45(62-12)33(2)18-21-41(59-9)31-46(63-13)37(6)47-28-39(29-50(57)65-47)27-42(26-32)60-10/h15-19,21-22,29,33-38,40-42,44-47,51-52H,20,23-28,30-31H2,1-14H3,(H,54,55)/b17-15+,21-18+,22-19+,32-16+/t33-,34-,35-,36-,37+,38-,40-,41+,42+,44+,45-,46-,47+,51-,52-/m0/s1 | 別名: | (4R,5R,9S,10S,11S)-4,10-DIMETHOXY-5,9-DIMETHYL-6-OXO-11-((3R,5Z,7Z,11S,12S,13Z,15R,17S,18S,19Z,21S,23S,24R,25R)-3,15,17
,21,23-PENTAMETHOXY-5,12,18,24-TETRAMETHYL-9,27-DIOXO-10,26-DIOXABICYCLO[23.3.1]NONACOSA-1(28),5,7,13,19-PENTAEN-11-YL)D
ODECANOIC ACID | 定義日: | 2005-08-30 | 最終更新日: | 2020-06-17 | 識別子(ID): | (4R,5R,9S,10S,11S)-4,10-dimethoxy-5,9-dimethyl-6-oxo-11-[(3R,5E,7E,11S,12S,13E,15R,17S,18S,19E,21S,23S,24R,25R)-3,15,17,21,23-pentamethoxy-5,12,18,24-tetramethyl-9,27-dioxo-10,26-dioxabicyclo[23.3.1]nonacosa-1(28),5,7,13,19-pentaen-11-yl]dodecanoic acid |
|
 | 1ON | 表記: | 2,3-dihydro-1H-inden-1-one | 組成式: | C9 H8 O | SMILES: | O=C2c1ccccc1CC2 | InChi: | InChI=1S/C9H8O/c10-9-6-5-7-3-1-2-4-8(7)9/h1-4H,5-6H2 | 別名: | 1-indanone | 定義日: | 2012-10-22 | 最終更新日: | 2020-06-17 | 公開日: | 2013-10-30 | 識別子(ID): | 2,3-dihydro-1H-inden-1-one |
|
 | RGT | 表記: | 2-amino-9-{5-O-[(R)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-ribofuranosyl}-9H-purin-6-yl
5-O-phosphono-beta-D-ribofuranoside | 組成式: | C15 H25 N5 O21 P4 | SMILES: | O=P(O)(O)OP(=O)(O)OP(=O)(O)OCC4OC(n2cnc1c(nc(nc12)N)OC3OC(C(O)C3O)COP(=O)(O)O)C(O)C4O | InChi: | InChI=1S/C15H25N5O21P4/c16-15-18-11-6(12(19-15)39-14-10(24)8(22)5(38-14)1-35-42(25,26)27)17-3-20(11)13-9(23)7(21)4(37-13)2-36-44(31,32)41-45(33,34)40-43(28,29)30/h3-5,7-10,13-14,21-24H,1-2H2,(H,31,32)(H,33,34)(H2,16,18,19)(H2,25,26,27)(H2,28,29,30)/t4-,5-,7-,8-,9-,10-,13-,14+/m1/s1 | 別名: | (Ribose-5'-phosphate)-(guanosine-5'-triphosphate) | 定義日: | 2008-07-31 | 最終更新日: | 2020-06-17 | 識別子(ID): | 2-amino-9-{5-O-[(R)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-ribofuranosyl}-9H-purin-6-yl 5-O-phosphono-beta-D-ribofuranoside |
|
 | 1P1 | 表記: | (22R,51R)-22,51-diamino-5,11,17,28,34,40,46,57-octamethyl-2,5,8,11,14,17,20,25,28,31,34,37,40,43,46,49,54,57,60,61,64,6
5-docosaazanonacyclo[54.2.1.1~4,7~.1~10,13~.1~16,19~.1~27,30~.1~33,36~.1~39,42~.1~45,48~]hexahexaconta-1(58),4(66),6,10(
65),12,16(64),18,27(63),29,33(62),35,39(61),41,45(60),47,56(59)-hexadecaene-3,9,15,21,26,32,38,44,50,55-decone | 組成式: | C52 H60 N24 O10 | SMILES: | O=C8Nc1nc(n(c1)C)C(=O)Nc2cc(n(c2)C)C(=O)Nc3cc(n(c3)C)C(=O)NCCC(N)C(=O)Nc4nc(n(c4)C)C(=O)Nc5nc(n(c5)C)C(=O)Nc6cc(n(c6)C)C(=O)Nc7cc(n(c7)C)C(=O)NCCC(N)C(=O)Nc9nc8n(c9)C | InChi: | InChI=1S/C52H60N24O10/c1-69-17-25-13-31(69)45(79)55-11-9-29(53)43(77)65-35-21-75(7)41(61-35)51(85)68-38-24-74(6)40(64-38)50(84)60-28-16-34(72(4)20-28)48(82)58-26-14-32(70(2)18-26)46(80)56-12-10-30(54)44(78)66-36-22-76(8)42(62-36)52(86)67-37-23-73(5)39(63-37)49(83)59-27-15-33(47(81)57-25)71(3)19-27/h13-24,29-30H,9-12,53-54H2,1-8H3,(H,55,79)(H,56,80)(H,57,81)(H,58,82)(H,59,83)(H,60,84)(H,65,77)(H,66,78)(H,67,86)(H,68,85)/t29-,30-/m1/s1 | 別名: | Cyclic Polyamide | 定義日: | 2009-07-10 | 最終更新日: | 2020-06-17 | 識別子(ID): | (22R,51R)-22,51-diamino-5,11,17,28,34,40,46,57-octamethyl-2,5,8,11,14,17,20,25,28,31,34,37,40,43,46,49,54,57,60,61,64,65-docosaazanonacyclo[54.2.1.1~4,7~.1~10,13~.1~16,19~.1~27,30~.1~33,36~.1~39,42~.1~45,48~]hexahexaconta-1(58),4(66),6,10(65),12,16(64),18,27(63),29,33(62),35,39(61),41,45(60),47,56(59)-hexadecaene-3,9,15,21,26,32,38,44,50,55-decone |
|
 | 1PB | 表記: | 1,4-DIPHENYL-2-BUTENE | 組成式: | C16 H16 | SMILES: | C(=C/c1ccccc1)CCc2ccccc2 | InChi: | InChI=1S/C16H16/c1-3-9-15(10-4-1)13-7-8-14-16-11-5-2-6-12-16/h1-7,9-13H,8,14H2/b13-7+ | 別名: | [(1E)-4-PHENYLBUT-1-ENYL]BENZENE | 定義日: | 2003-07-08 | 最終更新日: | 2020-06-17 | 識別子(ID): | 1,1'-(1E)-but-1-ene-1,4-diyldibenzene |
|
 | 1PC | 表記: | 1-(PHENYL-1-CYCLOHEXYL)PIPERIDINE | 組成式: | C17 H25 N | SMILES: | c1ccccc1C3(N2CCCCC2)CCCCC3 | InChi: | InChI=1S/C17H25N/c1-4-10-16(11-5-1)17(12-6-2-7-13-17)18-14-8-3-9-15-18/h1,4-5,10-11H,2-3,6-9,12-15H2 | 別名: | PHENCYCLIDINE | 定義日: | 1999-07-08 | 最終更新日: | 2020-06-17 | 識別子(ID): | 1-(1-phenylcyclohexyl)piperidine |
|
 | 1PD | 表記: | 2-({3-[5-hydroxy-2-(3-methylbutyl)-3-oxo-6-(1,3-thiazol-5-yl)-2,3-dihydropyridazin-4-yl]-1,1-dioxido-2H-1,2,4-benzothia
diazin-7-yl}oxy)acetamide | 組成式: | C21 H22 N6 O6 S2 | SMILES: | O=C4N(N=C(c1scnc1)C(O)=C4C3=Nc2c(cc(OCC(=O)N)cc2)S(=O)(=O)N3)CCC(C)C | InChi: | InChI=1S/C21H22N6O6S2/c1-11(2)5-6-27-21(30)17(19(29)18(25-27)14-8-23-10-34-14)20-24-13-4-3-12(33-9-16(22)28)7-15(13)35(31,32)26-20/h3-4,7-8,10-11,29H,5-6,9H2,1-2H3,(H2,22,28)(H,24,26) | 別名: | 2-({3-[5-hydroxy-2-(3-methylbutyl)-3-oxo-6-(1,3-thiazol-5-yl)-2,3-dihydropyridazin-4-yl]-1,1-dioxo-2H-1,2,4-benzothiadi
azin-7-yl}oxy)acetamide | 定義日: | 2008-01-11 | 最終更新日: | 2020-06-17 | 識別子(ID): | 2-({3-[5-hydroxy-2-(3-methylbutyl)-3-oxo-6-(1,3-thiazol-5-yl)-2,3-dihydropyridazin-4-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl}oxy)acetamide |
|
 | RHE | 表記: | rhenium (IV) hexachloride | 組成式: | Cl6 Re | SMILES: | Cl[Re](Cl)(Cl)(Cl)(Cl)Cl | InChi: | InChI=1S/6ClH.Re/h6*1H | 別名: | hexachlororhenate ion | 定義日: | 2010-03-22 | 最終更新日: | 2020-06-17 | 識別子(ID): | rhenium(6+) hexachloride |
|